Bridgeway Capital Management, LLC Matinas Bio Pharma Holdings, Inc. Transaction History

Bridgeway Capital Management, LLC

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 15, 2024	SELL	$0.19 - $0.3 $13,300 - $21,000	-70,000 Reduced 72.54%	26,500 $7,000
Q3 2023 Nov 14, 2023	SELL	$0.12 - $0.41 $12,000 - $41,000	-100,000 Reduced 50.89%	96,500 $12,000
Q2 2023 Aug 14, 2023	SELL	$0.35 - $0.72 $124,911 - $256,961	-356,891 Reduced 64.49%	196,500 $70,000
Q1 2023 May 15, 2023	SELL	$0.39 - $0.6 $39,000 - $60,000	-100,000 Reduced 15.3%	553,391 $260,000
Q4 2022 Feb 14, 2023	SELL	$0.46 - $42.69 $46,000 - $4.27 Million	-100,000 Reduced 13.27%	653,391 $326,000
Q4 2021 Feb 14, 2022	SELL	$0.92 - $1.22 $27,600 - $36,600	-30,000 Reduced 3.83%	753,391 $761,000
Q2 2021 Aug 16, 2021	BUY	$0.75 - $1.1 $78,750 - $115,500	105,000 Added 15.48%	783,391 $607,000
Q1 2021 May 17, 2021	SELL	$0.96 - $1.74 $377,960 - $685,053	-393,709 Reduced 36.72%	678,391 $712,000
Q4 2020 Feb 16, 2021	BUY	$0.76 - $1.47 $172,140 - $332,955	226,500 Added 26.79%	1,072,100 $1.46 Million
Q3 2020 Nov 16, 2020	BUY	$0.67 - $0.96 $87,502 - $125,376	130,600 Added 18.27%	845,600 $648,000
Q2 2020 Aug 14, 2020	BUY	$0.52 - $0.92 $195,000 - $345,000	375,000 Added 110.29%	715,000 $553,000
Q1 2019 May 15, 2019	BUY	$0.6 - $1.41 $204,000 - $479,400	340,000 New	340,000 $371,000
Q2 2018 Aug 14, 2018	SELL	$0.42 - $0.74 $79,380 - $139,860	-189,000 Closed	0 $0
Q4 2017 Feb 14, 2018	BUY	$1.1 - $1.54 $137,500 - $192,500	125,000 Added 195.31%	189,000 $219,000
Q3 2017 Nov 14, 2017	BUY	$1.19 - $1.43 $76,160 - $91,520	64,000	64,000 $84,000

3.52M

Ticker MTNB
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 216,864,992
Market Cap $130M
Description
Matinas BioPharma Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of various product candidates. It develops products using its lipid nanocrystal (LNC) platform technology. The company's LNC delivery technology platform utilizes lipid nano-crystals for the delivery of small molecules, nucleic ...

Get notified when there are updates to the investment portfolio of Bridgeway Capital Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Bridgeway Capital Management, LLC with notifications on news.